Versant Ventures Home

is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of twelve managing directors with more than 130 years of venture capital investing experience and more than 150 years of operating experience.

Versant Ventures currently manages over $1.6 billion in committed capital having recently raised its fourth fund in July 2008, and is currently managing over 75 companies in its portfolio.
 

  
Ross A. Jaffe MD, Managing Director Brian G. Atwood, Managing Director Camille D. Samuels, Managing Director Kevin J. Wasserstein, Managing Director
Robin L. Praeger, Managing Director and CFO Samuel D. Colella, Managing Director Kirk G. Nielsen, Investment Professional Donald B. Milder, Managing Director
  Rebecca B. Robertson, Managing Director Bradley J. Bolzon PhD, Managing Director William J. Link PhD, Managing Director
  Charles M. Warden, Managing Director Barbara N. Lubash, Managing Director
    Clare R. Ozawa PhD, Investment Professional Ian D. Sheffield, Investment Professional
     

 



©2007 Versant Venture Management LLC.  All rights reserved.
Site by Impend - Site Map